Guixing Ma
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Rehabilitation top 5%
- Wound Healing and Treatments
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- Bone Metabolism and Diseases 3
- Peroxisome Proliferator-Activated Receptors 2
-
- Tuberculosis Research and Epidemiology 4
- Co-authors
- Hongmin Zhang (8 shared papers)Huiling Cao (14 shared papers)Ashfaq Ahmad (3 shared papers)Yuechao Dong (4 shared papers)Yifan Zhu (2 shared papers)Hongzhe Sun (1 shared paper)Patrick C. Y. Woo (1 shared paper)Richard Yi-Tsun Kao (1 shared paper)
In The Last Decade
Guixing Ma
23 papers receiving 730 citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 220
- Rehabilitation 65
- Applied Microbiology and Biotechnology 19
- Biomaterials 63
- Endocrinology 23
Countries citing papers authored by Guixing Ma
This map shows the geographic impact of Guixing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixing Ma more than expected).
Fields of papers citing papers by Guixing Ma
This network shows the impact of papers produced by Guixing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixing Ma. The network helps show where Guixing Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Guixing Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 193 | |
| 2 | 2022 | 115 | |
| 3 | 2022 | 73 | |
| 4 | 2016 | 68 | |
| 5 | 2018 | 67 | |
| 6 | 2019 | 45 | |
| 7 | 2024 | 25 | |
| 8 | 2024 | 23 | |
| 9 | 2020 | 21 | |
| 10 | 2023 | 20 | |
| 11 | 2024 | 17 | |
| 12 | 2018 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2018 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Guixing Ma
Guixing Ma is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Molecular Medicine and Endocrinology, Diabetes and Metabolism, having authored 23 papers that have together received 734 indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (4 papers), Antibiotic Resistance in Bacteria (4 papers), Tuberculosis Research and Epidemiology (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Bone Metabolism and Diseases (3 papers), Mesenchymal stem cell research (3 papers), Diabetes and associated disorders (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Molecular Medicine (220 citations), Rehabilitation (65 citations), Applied Microbiology and Biotechnology (19 citations), Biomaterials (63 citations) and Endocrinology (23 citations). Guixing Ma has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Hongmin Zhang, Huiling Cao, Ashfaq Ahmad, Yuechao Dong, Yifan Zhu, Hongzhe Sun, Patrick C. Y. Woo, Richard Yi-Tsun Kao, Pak‐Leung Ho and Runming Wang. Their work appears in journals such as Cellular and Molecular Life Sciences, Nature Communications, Acta Pharmaceutica Sinica B, Protein & Cell and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.